Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis

Pan,Xiaofen; Lin,Zhixiu; Jiang,Danxian; Yu,Ying; Yang,Donghong; Zhou,Hechao; Zhan,Dechao; Liu,Sha; Peng,Gang; Chen,Zihong; Yu,Zhonghua

doi:10.3892/ol.2019.9888

Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis

Authors:
- Xiaofen Pan
- Zhixiu Lin
- Danxian Jiang
- Ying Yu
- Donghong Yang
- Hechao Zhou
- Dechao Zhan
- Sha Liu
- Gang Peng
- Zihong Chen
- Zhonghua Yu
View Affiliations

Affiliations: Department of Head and Neck Cancer, Oncology Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524000, P.R. China, Department of Pharmacy, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524000, P.R. China, Department of Oncology, Jingzhou Central Hospital, Jingzhou, Hubei 434020, P.R. China, Department of Head and Neck Cancer, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: January 4, 2019 https://doi.org/10.3892/ol.2019.9888
Pages: 3001-3008

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine whether erastin influences radioresistance in non‑small cell lung cancer (NSCLC) cells and produce a preliminary investigation into its mechanism of action. The radioresistant subtype of NSCLC cells, A549‑R and H460‑R, were induced by high‑dose hypofractionated irradiation. Erastin was used to treat the radioresistant cells and radiosensitivity was examined by colony formation assays. Cell death was determined after the cells were treated with erastin, irradiation (IR) or erastin together with IR. The expression of glutathione peroxidase 4 (GPX4) expression in the parental cells and radioresistance cells was detected by western blotting. GPX4 expression in the radioresistance cells was subsequently inhibited, radiosensitivity and cell death was measured, and erastin enhanced radiosensitivity in A549‑R and H460‑R cells. Erastin and IR exhibited a combined effect on killing cells, as co‑treatment with erastin and IR demonstrated a higher effect on killing cells compared with erastin or IR alone. GPX4 expression was inhibited by erastin in the radioresistant cells. Inhibiting GPX4 expression also radiosensitized NSCLC cells to radiation in the radioresistant cell lines. Erastin‑induced and GPX4‑inhibition‑induced cell death could partially be rescued by deferoxamine, but not Z‑VAD‑FMK and olaparib, which indicated that erastin and GPX4‑inhibition induced ferroptosis in the radioresistant cells. Erastin decreased radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis.

View Figures

View References

1	Li K, Liu J, Tian M, Gao G, Qi X, Pan Y, Ruan J, Liu C and Su X: CHMP4C disruption sensitizes the human lung cancer cells to irradiation. Int J Mol Sci. 17(pii): E182015. View Article : Google Scholar : PubMed/NCBI
2	Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al: SEER cancer statistics review (CSR). 1975-2015, National Cancer Institute; Bethesda, MD: https://seer.cancer.gov/csr/1975_2015/based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
3	Radovic M, Kanesvaran R, Rittmeyer A, Früh M, Minervini F, Glatzer M and Putora PM: Multidisciplinary treatment of lung cancer in older patients: A review. J Geriatr Oncol. Oct 3–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
4	Gower A, Wang Y and Giaccone G: Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. J Mol Med (Berl). 92:697–707. 2014. View Article : Google Scholar : PubMed/NCBI
5	Nguyen KS, Neal JW and Wakelee H: Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol. 5:576–587. 2014. View Article : Google Scholar : PubMed/NCBI
6	Dolma S, Lessnick SL, Hahn WC and Stockwell BR: Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 3:285–296. 2003. View Article : Google Scholar : PubMed/NCBI
7	Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 447:864–868. 2007. View Article : Google Scholar : PubMed/NCBI
8	Yang WS and Stockwell BR: Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
9	Dixon SJ and Stockwell BR: The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 10:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
10	Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
11	Wolpaw AJ, Shimada K, Skouta R, Welsch ME, Akavia UD, Pe'er D, Shaik F, Bulinski JC and Stockwell BR: Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci USA. 108:E771–E780. 2011. View Article : Google Scholar : PubMed/NCBI
12	Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, Zeh HJ, Kang R and Tang D: The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2:e10545492015. View Article : Google Scholar : PubMed/NCBI
13	Sun X, Niu X, Chen R, He W, Chen D, Kang R and Tang D: Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology. 64:488–500. 2016. View Article : Google Scholar : PubMed/NCBI
14	Ivanov SD, Semenov AL, Mikhelson VM, Kovan'ko EG and Iamshanov VA: Effects of iron ion additional introduction in radiation therapy of tumor-bearing animals. Radiats Biol Radioecol. 53:296–303. 2013.PubMed/NCBI
15	Ivanov SD, Semenov AL, Kovan'ko EG and Yamshanov VA: Effects of iron ions and iron chelation on the efficiency of experimental radiotherapy of animals with gliomas. Bull Exp Biol Med. 158:800–803. 2015. View Article : Google Scholar : PubMed/NCBI
16	El Osta BE, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, et al: Characteristics and outcomes of patients (pts) with metastatic KRAS mutant lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC) database. J Clin Oncol. 35 (15 Suppl):S90212017. View Article : Google Scholar
17	Kwon MY, Park E, Lee SJ and Chung SW: Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 6:24393–24403. 2015. View Article : Google Scholar : PubMed/NCBI
18	Yu JA, Li H, Meng X, Fullerton DA, Nemenoff RA, Mitchell JD and Weyant MJ: Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells. J Thorac Cardiovasc Surg. 144:1479–1485. 2012. View Article : Google Scholar : PubMed/NCBI
19	Vigil D, Cherfils J, Rossman KL and Der CJ: Ras superfamily GEFs and GAPs: Validated and tractable targets for cancer therapy? Nat Rev Cancer. 10:842–857. 2010. View Article : Google Scholar : PubMed/NCBI
20	Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND and Lee H: The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiat Res. 156:739–750. 2001. View Article : Google Scholar : PubMed/NCBI
21	Peng G, Cao RB, Li YH, Zou ZW, Huang J and Ding Q: Alterations of cell cycle control proteins SHP1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells. Mol Med Rep. 10:1709–1716. 2014. View Article : Google Scholar : PubMed/NCBI
22	Hall EJ and Giaccia AJ: Radiobiology for the radiologist. Section I, Chapter 3. Cell survival curves. 7th. Wolters Kluwer Health/ Lippincott Williams & Wilkins; Philadelphia, PA, USA: pp. 2–51. 2012
23	Wu L, Liu YY, Li ZX, Zhao Q, Wang X, Yu Y, Wang YY, Wang YQ and Luo F: Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis. Asian Pac J Cancer Prev. 15:489–494. 2014. View Article : Google Scholar : PubMed/NCBI
24	Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
25	Tor YS, Yazan LS, Foo JB, Wibowo A, Ismail N, Cheah YK, Abdullah R, Ismail M, Ismail IS and Yeap SK: Induction of apoptosis in MCF-7 cells via oxidative stress generation, mitochondria-dependent and caspase-independent pathway by ethyl acetate extract of dillenia suffruticosa and its chemical profile. PLoS One. 10:e01274412015. View Article : Google Scholar : PubMed/NCBI
26	Yang KS, Kohler RH, Landon M, Giedt R and Weissleder R: Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 5:101292015. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Pan K, Chen L, Ning JL, Li X, Yang T, Terrando N, Gu J and Tao G: Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. J Neuroinflammation. 13:2682016. View Article : Google Scholar : PubMed/NCBI
28	Fang S, Yu X, Ding H, Han J and Feng J: Effects of intracellular iron overload on cell death and identification of potent cell death inhibitors. Biochem Biophys Res Commun. 503:297–3029. 2018. View Article : Google Scholar : PubMed/NCBI
29	Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 520:57–62. 2015. View Article : Google Scholar : PubMed/NCBI
30	Louandre C, Marcq I, Bouhlal H, Lachaier E, Godin C, Saidak Z, François C, Chatelain D, Debuysscher V, Barbare JC, et al: The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Lett. 356:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
31	Lachaier E, Louandre C, Godin C, Saidak Z, Baert M, Diouf M, Chauffert B and Galmiche A: Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res. 34:6417–6422. 2014.PubMed/NCBI
32	Conrad M and Friedmann Angeli JP: Glutathione peroxidase 4 (Gpx4) and ferroptosis: What's so special about it? Mol Cell Oncol. 2:e9950472015. View Article : Google Scholar : PubMed/NCBI
33	Seiler A, Schneider M, Förster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, et al: Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8:237–248. 2008. View Article : Google Scholar : PubMed/NCBI
34	Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, et al: Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 1:223–232. 2005. View Article : Google Scholar : PubMed/NCBI